Scott Hadland, MD, MPH, MS
CARE Unit Faculty
Associate Professor of Pediatrics, Boston University School of Medicine
Scott Hadland is an Associate Professor of Pediatrics and a pediatrician and addiction specialist at Boston Medical Center and Boston University School of Medicine. He holds triple board certification in General Pediatrics, Adolescent Medicine, and Addiction Medicine. Dr. Hadland’s clinical and research interests focus on adolescent and young adult substance use disorder prevention and treatment, and on improving care for youth and families affected by substance use. As part of these efforts, he seeks to improve education on addiction to pediatricians in the US and beyond. Dr. Hadland has also studied the potential influence of the pharmaceutical industry in physician prescribing of opioids and stimulants.
Collectively, Dr. Hadland’s 13 mentees have received three national research awards under his direct supervision and published 11 peer-reviewed articles in leading journals. His work has been published in leading journals, including The Lancet, BMJ, Pediatrics, JAMA Internal Medicine, and Addiction. Dr. Hadland is on the Editorial Board for the journal Pediatrics, and previously served on the Editorial Board of the Journal of Adolescent Medicine and was an Associate Editor for the International Journal of Drug Policy. He has received funding from the National Institute on Drug Abuse, Thrasher Research Fund, and Academic Pediatric Association, and he has been featured in The New York Times, Washington Post, CNN, NBC News, CBS News, National Public Radio, and other leading news outlets.
Boston University faculty appointment: 2016
Areas of Specialization
- Board-certified, Adolescent Medicine
- Board-certified, Addiction Medicine
- Board-certified, General Pediatrics
- Specialization in care of youth, addiction, and LGBTQ health
Education and Training
Harvard-Wide Pediatric Health Services Research Fellowship, Boston, MA 2014-2016
Adolescent Medicine, Boston Children’s Hospital, Boston, MA 2013-2015
Pediatrics, Boston Medical Center / Boston Children’s Hospital, Boston, MA 2009-2012
MD, Washington University in St. Louis, St. Louis, MO
MPH (Epidemiology & Biostatistics), Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
MS (Health Policy and Management), Harvard T. H. Chan School of Public Health, Boston, MA
BS (Physiology (major), Psychology (minor)), McGill University, Montreal, QC
Honors & Awards
- Emerging Leader in Adolescent Health Award, American Academy of Pediatrics, 2020
- New Investigator / Educator Award, Association for Multidisciplinary Education and Research in Substance use and Addiction, 2020
- New Investigator Award, Society for Adolescent Health and Medicine, 2016
Alinsky RH, Zima BT, Rodean J, Matson PA, Larochelle MR, Adger H Jr, Bagley SM, Hadland SE. Receipt of Addiction Treatment After Opioid Overdose Among Medicaid-Enrolled Adolescents and Young Adults. JAMA Pediatr. 2020:e195183.
Hadland SE, Cerdá M, Li Y, Krieger MS, Marshall BD. Pharmaceutical Industry Marketing of Opioid Products to Physicians and Subsequent Opioid Prescribing. JAMA Intern Med. 2018; 178(6):861-863.
Hadland SE, Bagley SM, Rodean J, Silverstein M, Levy S, Larochelle MR, Samet JH, Zima BT. Receipt of Timely Addiction Treatment and Association of Early Medication Treatment With Retention in Care Among Youths With Opioid Use Disorder. JAMA Pediatr. 2018;172(11):1029-1037.
Hadland SE, Wood E, Levy S. How the paediatric workforce can address the opioid crisis. Lancet. 2016;388(10051):1260-1.
Hadland SE, DeBeck K, Kerr T, Nguyen P, Simo A, Montaner JS, Wood E. Use of a medically supervised injection facility among street youth. J Adolesc Health. 2014;55(5):684-9.